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Abstract
The study objective was to facilitate investigations by assessing the external validity and generalizability of the
Centricity Electronic Medical Record (EMR) database and analytical results to the US population using the
National Ambulatory Medical Care Survey (NAMCS) data and results as an appropriate validation resource.
Demographic and diagnostic data from the NAMCS were compared to similar data from the Centricity EMR
database, and the impact of the different methods of data collection was analyzed.
Compared to NAMCS survey data on visits, Centricity EMR data shows higher proportions of visits by
younger patients and by females. Other comparisons suggest more acute visits in Centricity and more chronic
visits in NAMCS. The key finding from the Centricity EMR is more visits for the 13 chronic conditions high-
lighted in the NAMCS survey, with virtually all comparisons showing higher proportions in Centricity.
Although data and results from Centricity and NAMCS are not perfectly comparable, once techniques are
employed to deal with limitations, Centricity data appear more sensitive in capturing diagnoses, especially
chronic diagnoses. Likely explanations include differences in data collection using the EMR versus the survey,
particularly more comprehensive medical documentation requirements for the Centricity EMR and its inclusion
of laboratory results and medication data collected over time, compared to the survey, which focused on the
primary reason for that visit. It is likely that Centricity data reflect medical problems more accurately and
provide a more accurate estimate of the distribution of diagnoses in ambulatory visits in the United States.
Further research should address potential methodological approaches to maximize the validity and utility of
EMR databases. (Population Health Management 2010;13:139–150)
Agrowing proportion of US ambulatory care physicianpractices are adopting electronic medical record (EMR)
systems to support various clinical processes including doc-
umentation of patient encounters and secure exchange of data
with other providers. In 2007, one leading commercial EMR
system, GE Centricity,a was used by more than 20,000 clini-
cians to manage the medical records of about 30 million pa-
tients in 49 states. These electronic records contain a wide
range of clinical and demographic variables. A structured
user interface supports accurate and consistent documenta-
tion by physicians and supports internal data validity, both
individually and in the aggregate. A significant attribute of
Centricity, like other EMRs, is its capacity to track patients’
clinical conditions over time. Taken together, these attributes
of Centricity and other EMRs make them rich resources for
epidemiologic, population health, and outcomes research.
Specifically, the Centricity EMR data structure supports
multivariate analytic designs including retrospective cohort
1Thomas Jefferson University School of Population Health, Philadelphia, Pennsylvania.
2Johnson & Johnson, Corporate Office of Science and Technology, New Brunswick, New Jersey.
3S2 Statistical Solutions, Inc., Cincinnati, Ohio.
4Ethicon Endo-Surgery, Inc., Scientific Affairs/Medical Affairs, New Brunswick
5Johnson & Johnson, Office of Evidence Based Medicine, Medical Device and Diagnostics, New Brunswick, New Jersey.
aCentricity Physician Office is a registered trademark of GE Medical Systems Information Technologies.
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studies. Researchers’ interest in Centricity is already evident
in the growing medical research literature that is reviewed in
this paper.
The purpose of this investigation is to facilitate future in-
vestigations by assessing the external validity and general-
izability of Centricity data and analytic results to the US
population as a whole. Our literature review identified
the National Ambulatory Medical Care Survey (NAMCS) as
an appropriate validation resource for this study. Supported
by the Federal Centers for Disease Control and Preven-
tion (CDC), NAMCS collects data regarding patient visits
from a sample of physicians. Like Centricity, the NAMCS
provides a de-identified data set that includes patients’
demographic characteristics, physicians’ diagnoses, and
medications ordered and/or provided. NAMCS also pub-
lishes reports with descriptive statistics on patients’ demo-
graphic characteristics and conditions including diagnoses
and treatments. However, the 2 data sets employ different
methods of data collection: NAMCS collects data from
physicians using a survey tool at the time of the patient visit,
posing a modest threat to internal validity, while the Cen-
tricity data set is based on an EMR, in which high data
quality stem from professional responsibility, the neglect of
which could compromise quality care and endanger patient
safety. NAMCS data include sample weights that allow
making statistical inferences from its national probability
sample, providing a basis for interpreting possible deviations
between nationally representative NAMCS results and cor-
responding results derived from the Centricity EMR data-
base. We evaluated a number of demographic, diagnostic,
and disease state variables for external validity and gener-
alizability.
Background
A review of the peer-reviewed literature provides a basis
for the present effort to assess the external validity and
generalizability of the GE Centricity EMR data set and its
capacity to support population-level research on chronic
conditions in the United States. Although the methods em-
ployed in this literature review were not formal, we believe
that the results are valid, especially given our ability to query
Centricity staff about all publications to date based on Cen-
tricity EMR data.
Our review includes several examples of recently pub-
lished research that employed secondary analyses of federal
data sets and/or data derived from widely used EMR sys-
tems.
In a study by Burt and associates,1 data from NAMCS and
its counterpart in hospitals, the National Hospital Ambulatory
Medical Care Survey (NHAMCS), were used to investigate
physician treatment and prescribing patterns. Specifically,
using a multiplicity estimator, NAMCS and NHAMCS data on
the number of past visits the patient made to the sample
provider during the 1-year period prior to the sampled visit
were used to estimate the number of patients. The resulting
distribution of patients by annual number of visits is similar to
the estimated distribution of persons in the United States
making ambulatory care visits based on a population-based
survey.
Another recent report, by Hing and associates,2 describes
ambulatory visits to physician offices in the United States
and presents statistics on selected characteristics of physician
practices, patients, office visits, and trends in visits. The data
were collected in the 2004 NAMCS and were weighted to
produce annual national estimates by employing an estima-
tor using revised non-response adjustment. The authors
found that in 2004 an estimated 910.9 million visits were
made to physician offices in the United States, an overall rate
of 315.9 visits per 100 persons, with 58.9% of visits to phy-
sicians in the specialties of general and family practice, in-
ternal medicine, pediatrics, and obstetrics and gynecology.
Essential hypertension, malignant neoplasms, acute upper
respiratory infection, and diabetes mellitus were the leading
illness-related primary diagnoses.
An earlier paper by Machlin and colleagues3 compared
1996 survey estimates using NAMCS, NHAMCS, the Medi-
cal Expenditure Panel Survey, and the National Health In-
terview Survey and described methodological issues to
consider when using these data sets to measure ambulatory
utilization.
There has been considerable research in the last few years
based on analyses of Centricity EMR data. In fact, focusing
on just US national research using Medical Quality Im-
provement Consortium (MQIC) data in particular, there
were 12 journal publications during 2006–2007, and 31
poster/podium presentations during 2004–2008.4 For exam-
ple, Brixner and colleagues5 used clinical (biometric), diag-
nosis (ICD-9-CM codes), and treatment (prescription)
information in the Centricity EMR database to examine the
prevalence of cardiometabolic risk (CMR) factors that con-
tribute to metabolic syndrome in the primary care setting. In
the study population of 475,651 patients with information on
indicators of CMR, 15.3% and 11.8% were found to have
metabolic syndrome according to National Cholesterol Edu-
cation Program and International Diabetes Federation crite-
ria, respectively; 34.2% had a body mass index (BMI) 27kg/
m2 as a risk factor, 56.0% had high blood pressure, 10.7% had
high triglycerides, 16.0% had low high-density lipoprotein
cholesterol (HDL-C), 8.8% had impaired fasting glucose, and
7.2% had diabetes. Brixner and colleagues conclude that ‘‘the
distribution of CMR factors in a primary care database is
similar to that established by prospective national health
surveys such as NAMCS. A key source of identification of
risk factors are clinical outcomes including BMI and lab val-
ues. Future studies on metabolic syndrome need to link
clinically based information with more readily available
treatment and diagnosis information.’’
In a 2008 article, Brixner and colleagues6 evaluated the
relationships between CMR factors and BMI as recorded in
the Centricity EMR. Patients with a BMI 18 kg/m2 in the
EMR at any time during the 10-year period from 1996–2005
were stratified into groups by number of CMR factors, and
individual risk factor for those with only 1. The authors
identified a total of 499,593 patients with a BMI 18 kg/m2;
56.4% had a BMI> 27 kg/m2, while 43.6% had a BMI of
18–27 kg/m2. Compared with patients with no risk factors,
patients with 1-4 risk factors were significantly more likely to
have a BMI> 27 kg/m2; 48.4% without CMR factors had a
BMI> 27 kg/m2, compared with 63.3%, 79.8%, 84.6%, and
88.5% for patients with 1-4 cardiometabolic risk factors, re-
spectively. Adjusted odds ratios (ORs) for having a
BMI> 27 kg/m2 were 2.64 for type 2 diabetes, 2.21 for ele-
vated triglycerides, 1.91 for hypertension, and 1.45 for low
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HDL-C. Adjusted ORs for having a BMI> 27 kg/m2 were
3.58 for patients with any 2 risk factors, 4.24 for patients with
any 3 risk factors, and 5.07 for patients with any 4 risk fac-
tors, relative to patients with no CMR factors. Brixner and
colleagues conclude that ‘‘For patients with cardiometabolic
risk factors, compared with patients with no risk factors, the
odds of having a BMI> 27 kg/m2 were multiplied by 1.45–
5.07, depending on the type and number of risk factors. Di-
agnoses and treatment indicators for cardiometabolic risk
factors are potential indicators of obesity.’’
In another recent use of secondary data from the Cen-
tricity EMR database, Wang and colleagues7 compared the
risk of incident hypertension associated with the use of cel-
ecoxib and nonselective non-steroidal anti-inflammatory
drugs (NSAIDs).
One of the most relevant and useful analyses of Centricity
EMR data, especially for the present analyses, is Gill and
Chen’s 2008 evaluation of lipid management,8 which in-
cludes adequate lipid testing, achievement of lipid goals, and
appropriate use of lipid-lowering medication. Lipid testing
was adequate for 62% of high-risk, 67% of moderate-risk,
and 36% of low-risk patients. Lipid goals were achieved in
65% of high-risk, 66% of moderate-risk, and 90% of low-risk
patients; 35% of high-risk, 45% of moderate-risk, and 32% of
low-risk patients achieved adequate testing and optimal
goals; and medications were appropriately prescribed for
70% of high-risk, 47% of moderate-risk, and 48% of low-risk
patients. Gill and Chen note that ‘‘National EHR networks
are excellent vehicles for large outpatient quality of care
studies, particularly for measuring clinical outcomes such as
lipid levels.’’
In summary, these studies show that national EMR data-
bases such as Centricity are valuable tools for health services
research including epidemiologic and outcomes research and
studies of provider behavior. EMR data sets have several
attributes that provide significant opportunities for such re-
search. First, identification of a patient’s primary reason for a
visit not only provides deeper information than that avail-
able in International Classification of Diseases, Ninth Revision,
Clinical Modification (ICD-9-CM) diagnosis codes in claims
databases, but it also allows cross-tabulation with disease
state and prescribing information. Second, a data set derived
from algorithm-based extraction of data from EMRs is in-
herently more comprehensive and accurate than a data set
derived from patient- or visit-level survey records, the va-
lidity of which depends on the cooperation and attention of
responding physicians and office staff. The factorial analysis
of metabolic syndrome by Brixner and colleagues5 is an early
indicator of the potential for multivariate analyses of EMR
data, specifically investigations of comorbidities and disease
staging. Currently, results of such studies may be of limited
generalizability to the degree that patient demographic and
clinical characteristics represented in EMR data sets have not
been validated as representative of the US population.
Comparing patient attributes represented in the NAMCS
data to those in the MQIC data set derived from the GE
Centricity EMR, the present study provides such results to
address the generalizability of this EMR-based data set.
Specifically, the analysis explores various factors (ie, differ-
ences in data collection methods) that pose potential ana-
lytical limitations. The results are intended to provide insight
into the strengths and weaknesses of the GE Centricity EMR
as a tool for population health research, informing future
studies and stimulating promising lines of research.
Methods
National Ambulatory Medical Care Survey
As described on the CDC Web site,9 ‘‘The National Am-
bulatory Medical Care Survey (NAMCS) is a national survey
designed to meet the need for objective, reliable information
about the provision and use of ambulatory medical care
services in the United States. Findings are based on a sample
of visits to non-federally employed office-based physicians
who are primarily engaged in direct patient care. Physicians
in the specialties of anesthesiology, pathology, and radiology
are excluded from the survey. The survey [has been]
conducted… annually since 1989.’’
‘‘Specially trained interviewers visit the physicians prior to
their participation in the survey in order to provide them
with survey materials and instruct them on how to complete
the forms. Data collection from the physician, rather than
from the patient, provides an analytic base that expands
information on ambulatory care collected through other
NCHS surveys. Each physician is randomly assigned to a
1-week reporting period. During this period, data for a sys-
tematic random sample of visits are recorded by the physi-
cian or office staff on an encounter form provided for that
purpose. Data are obtained on patients’ symptoms, physi-
cians’ diagnoses, and medications ordered or provided. The
survey also provides statistics on the demographic charac-
teristics of patients and services provided, including infor-
mation on diagnostic procedures, patient management, and
planned future treatment.’’9
An enhancement implemented in the 2005 NAMCS
allowed chronic condition-specific comparisons: ‘‘The em-
phasis for the 2005 survey year was chronic conditions.
Additions to the routine encounter data that related to
chronic conditions included: a chronic disease checklist, in-
cluding conditions affecting the respiratory, cardiovascular,
renal, and endocrine systems; arthritis; cancer; depression;
obesity; and osteoporosis.’’9
GE Centricity database
The GE Centricity EMR database captures patient-level
clinical data elements obtained from the Centricity Physician
Office EMR (formerly Logician) for Clinical Data Services
(CDS) reporting. The Centricity ambulatory care EMR and its
predecessors have been used for over 20 years, are certified
by the Certification Commission for Healthcare Information
Technology (CCHIT), and are currently used by over 30,000
clinicians in the United States. Centricity CDS includes data
provided by 7259 clinicians (including approximately 60%
primary care providers and 40% specialists) at 98 installa-
tions with 133 unique provider members. CDS includes
de-identified, standardized data on more than 8,900,000
patients; and the data on at least half of these patients spans
more than 985 days, for a median of approximately 2.7 years
of continuous care.
While the present study uses all data in CDS, some re-
search cited in our literature review analyzes data generated
by MQIC, a national network of outpatient practices. All
practices that use the Centricity EMR are invited to join
MQIC, but membership in MQIC is completely voluntary. In
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2008 MQIC included over 4,000,000 patients cared for by
over 5000 physicians and other providers from over 90 in-
stitutions in 35 states throughout the United States. These
practices ranged from solo practices to large multipractice
institutions with over 1000 providers; roughly 63% of MQIC
providers are primary care physicians (including family
medicine, general internal medicine, general pediatrics, and
geriatrics).
Exclusion criteria applied to the Centricity EMR data
Exclusion criteria and algorithms were developed to
eliminate potential distortions in aggregated Centricity EMR
data resulting from user interface design, database structure,
the de-identification process, or methods of recording pro-
cedures. Problem/complaint text extracted from records was
filtered to ensure that patients merely evaluated for a con-
dition (without confirmation of diagnosis) were not counted
as ‘‘positives’’ along with patients explicitly diagnosed with
that condition (included in this process of elimination are
diagnoses containing ‘‘family history of,’’ ‘‘rule out,’’ ‘‘risk
of,’’ ‘‘screening of,’’ ‘‘symptoms of,’’ and ‘‘question of’’). Ex-
clusion criteria were also employed to reduce the likelihood
of overestimation resulting from ‘‘backfilling’’ of retrospec-
tive visit data for physician practices when they first adopt
the Centricity EMR.
Office visits and study population
This analysis uses 2005 GE Centricity EMR data on ‘‘ac-
tivities’’ and patient demographics. Several sets of inclusion/
exclusion criteria were applied prior to analysis (Figure 1).
First, all 2005 activity data were extracted from the database
(Step 1). The index date range was from January 1, 2005 to
December 31, 2005. Then, patients who had an activity re-
cord in 2005 and at least 1 documented activity in both 2004
and 2006 were selected to assure that they were active and
still in the same health care system throughout 2005 (Step 2).
According to the NAMCS 2005 summary report,10 NAMCS
excludes office visits to physicians in the specialties of an-
esthesiology, pathology, and radiology. In the GE Centricity
EMR database, 56% of the patients’ specialty information
was listed as ‘‘unknown.’’ Among the 3.9 million patients
with specialty information, specialty data for only 872 pa-
tients indicated the 3 specialties of anesthesiology, pathol-
ogy, or radiology. Specialty information provided by the
responsible service provider was patient based, and activity
data did not include specialty information. Therefore, this
selection criterion was not applied to the data. In NAMCS,
certain types of contacts were also excluded, including those
made by telephone, those made outside the physician’s office
(eg, house calls), visits made in hospital settings (unless the
physician has a private office in a hospital and that office
meets the NAMCS definition of an ‘‘office’’), visits made in
institutional settings by patients for whom the institution has
primary responsibility over time (eg, nursing homes), and
visits to doctors’ offices that are made for administrative
purposes only (eg, to leave a specimen, pay a bill, pick up
insurance forms). Therefore, among the various activity
types, only activities meeting these ‘‘office visit’’ criteria were
included in the study (Step 3). In addition to the criteria
mentioned earlier, a small number of patients had missing
sex and/or age information and were excluded from the final
analysis data set (Step 4).
In the 2005 NAMCS survey data, only a single ‘‘primary’’
ICD-9-CM diagnosis code was recorded by physicians
(see Tables 2 and 3), and additional chronic conditions were
recorded through checkbox responses regardless of visit
diagnosis. In the GE Centricity EMR database, however,
activity data were available from multiple sources: problem,
complaint, medication, prescription, observation, and order
data. To maximize the validity of the comparison of data in
the 2 data sets, only office visits associated with the problem
table (only visits which resulted in 1 or more ICD-9-CM di-
agnosis codes) were included in the analyses reported in
Table 2 (Step 5). In situations where more than 1 ICD-9-CM
diagnosis code is listed during a single office visit, a fraction
of each ICD-9-CM code was calculated by dividing 1 into the
total number of ICD-9-CM diagnosis codes, and this fraction
was used to calculate the annual number of visits with
specified ICD-9-CM codes. A small number of ICD-9-CM ‘‘E’’
(external injury) codes were present in the database; these
were included in the ‘‘other’’ category in Table 2.
For the chronic disease comparisons shown in Table 3, we
first identified the corresponding ICD-9-CM diagnosis codes
and searched the problem data set for these codes through
the end of 2005. The diagnosis codes for these chronic dis-
eases are listed in the Notes for Table 3. All chronic diseases
were considered separately, and the fractional approach
described above was not applied in this part of the analysis.
Analytic methods
Standard errors of percentages published for the NAMCS
data were used to generate 99% confidence intervals, to
GE Centricity Database (Jan. 1st 1996 – Mar. 31st 2008) 
Patient population: 8,901,057 
Activity count: 412,175,606 
Step 1 
GE Centricity Database (Jan. 1st – Dec. 31st 2005) 
Patient population: 3,683,868 
Activity count: 57,634,290 
Step 2 
GE Centricity Database (Jan. 1st – Dec. 31st 2005) 
Inclusion criteria: At least 1 documented activity in  
both 2004 and 2006 
Patient population: 1,816,664 
Activity count: 39,374,063 
Step 3 
GE Centricity Database (Jan. 1st – Dec. 31st 2005) 
Inclusion criteria: Activity type needs to be an “office visit” 
Patient population: 1,462,126 
Activity count: 6,202,445 
Step 4 
GE Centricity Database (Jan. 1st – Dec. 31st 2005) 
Inclusion criteria: non-missing sex and age 
Patient population: 1,462,002 
Activity count: 6,201,616 
(Final 2005 office visit data for Table 1) 
Step 5 
GE Centricity Database (Jan. 1st – Dec. 31st 2005) 
Inclusion criteria: Visits with an ICD-9-CM diagnosis  
Patient population: 950,431 
Activity count: 2,210,587 
(Final 2005 office visit data for Tables 2-3) 
FIG. 1. Steps in the selection of office visits.
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which point estimates generated for the Centricity EMR data
were compared to yield conclusions about statistically sig-
nificant differences at the P< .01 level between the 2 sets
of results. Given the very large numbers involved, almost
all of the differences examined were statistically significant.
The actual percentage differences were then reexamined to
assess the substantive significance of each finding, with a
criterion of a difference of at least 2% to indicate substantive
significance.
Results
Table 1 compares NAMCS and GE Centricity EMR results
on the number and percent distribution of office visits, with
corresponding standard errors, by patient age and sex for the
United States for 2005. The GE Centricity EMR data include
higher proportions of patient visits for ages up to age 64 and
lower proportions for ages 65 and older, as follows: 18.0% vs.
16.7% for younger than age 15 years, 8.6% vs. 7.3% for ages
15–24 years, 22.0% vs. 20.9% for ages 25–44 years, 29.9% vs.
29.4% for ages 45–64 years, 10.8% vs. 12.4% for ages 65–74
years, and 10.7% vs. 13.3% for ages 75 years and older. While
all 6 of these differences are statistically significant (P< .01),
they appear relatively modest. On the other hand, the GE
Centricity EMR data include a significantly and substantially
higher percentage of female patient visits (63.3% vs. 58.2%,
P< .01).
Table 2 compares NAMCS and GE Centricity EMR results
on the number and percent distribution of office visits by
physician’s primary diagnosis. The comparison is problem-
atic in that the GE Centricity EMR data include a signifi-
cantly higher proportion of visits with diagnoses in the
symptoms, signs, and ill-defined conditions category (16.0%
vs. 6.3%, P< .01) and significantly lower proportions in the
supplementary classification, all other diagnoses, and un-
known categories (11.9% vs. 18.6%, 1.5% vs. 2.7%, and 0.0%
vs. 0.9%, all P< .01), with a combined difference across these
3 categories of 13.3% vs. 22.2%. Given a close correspondence
between the NAMCS and GE Centricity EMR in the overall
proportions in all 4 residual categories combined (28.5% vs.
29.3%), we will compare differences in the more substantive
diagnostic categories, but we will do so with the required
caution. All 11 such comparisons are statistically significant
(P< .01); however, only 3 seem noteworthy - the lower
proportions of neoplasm and circulatory condition diagnoses
(1.2% vs. 4.1% and 3.6% vs. 8.5%, respectively), and the
higher proportion of respiratory condition diagnoses (17.9%
vs. 11.5%).
Table 3 compares NAMCS and GE Centricity results
for the number and percent distribution of office visits by
selected chronic conditions for the United States for 2005.
The Centricity database is substantially more likely than the
NAMCS data to show at least 1 condition (63.4% vs. 52.7%)
and substantially less likely to show none (36.6% vs. 43.8%)
or blank (0.0% vs. 3.5%). Of 13 possible comparisons re-
garding selected chronic diagnoses, all showed statistically
significant differences between the 2 data sets, and all but 1
showed a higher proportion in the Centricity data: hyper-
tension (24.4% vs. 22.8%), hyperlipidemia (25.7% vs. 13.5%),
diabetes (10.2% vs. 9.8%), depression (16.0% vs. 8.8%), obe-
sity (8.9% vs. 7.1%), cancer (14.4% vs. 5.9%), asthma (10.7%
vs. 5.7%), chronic obstructive pulmonary disease (COPD;
10.3% vs. 4.2), ischemic heart disease (6.1% vs. 4.1%), cere-
brovascular disease (4.2% vs. 1.9%), congestive heart failure
(3.5% vs. 1.6%), and chronic renal failure (2.9% vs. 1.2%). The
one exception to the pattern detailed above was the higher
percentage of visits with a diagnosis of arthritis in NAMCS
vs. Centricity (14.3% vs. 13.2%). Five of the differences are
especially sharp (ie, exceeding 5%): those for hyperlipidemia,
depression, cancer, asthma, and COPD.
Discussion
Regarding demographic data, comparisons of NAMCS
and Centricity EMR patient visits by age and sex show that
Centricity visits are somewhat more likely to involve youn-
ger patients (the 6 percentage differences by age group
ranged from 0.9%–2.6%), and substantially more likely to
involve females (5.1%). Although all of these differences are
statistically significant, given the large sample size, we be-
lieve that sex may have more potential for confounding than
age. This issue should be addressed by additional research.
Comparisons of NAMCS and Centricity EMR results for
physician’s primary diagnosis show lower proportions of
neoplasm and circulatory condition diagnoses in Centricity
and a higher proportion of respiratory condition diagnoses,
suggesting relatively more visits for chronic conditions in
NAMCS and relatively more visits for acute conditions in
Centricity.
Turning to the selected chronic conditions highlighted in
the NAMCS results, the Centricity data include a substan-
tially higher proportion of visits with at least 1 condition and
a substantially lower proportion with none of the selected
chronic conditions. Of the 13 possible chronic diagnosis
comparisons, all but 1 (ie, arthritis) showed a significantly
higher proportion in the Centricity data.
Among the potential explanations for the apparent greater
sensitivity of Centricity data to chronic condition diagnoses
are (1) methodological differences between the NAMCS and
Centricity data collection approaches and data sets, (2) dif-
ferential characteristics of providers who use EMRs like
Centricity, and (3) in particular, differential characteristics of
providers who not only use an EMR but also participate in a
data collection and analysis program like MQIC.
Regarding the first potential explanation, the key meth-
odological difference in data collection is that the NAMCS
focuses on the ‘‘primary reason for the visit,’’ while Centricity
accumulates all problems and diagnoses and thus has greater
capacity to identify all relevant diagnoses. Moreover, data
extracted from the Centricity EMR using algorithms to
maximize validity may be inherently more comprehensive
and accurate than patient- or visit-level survey data, the
validity of which depends on the motivation of patients,
physicians, other clinicians, and office staff. Additional
strengths of the Centricity EMR database are (1) its incor-
poration of documentation of a wide range of diagnostic and
therapeutic services, specifically laboratory test results and
medications ordered, and (2) its incorporation of all such
data over time, allowing greater sensitivity in capturing di-
agnoses. As a result, it is likely that the Centricity data reflect
more of the medical problems that motivated patient visits
than the NAMCS data.
At least 2 specific interpretations of our major findings
relate to the differential characteristics of EMRs and the
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providers who adopt them. First, EMRs facilitate more
complete and accurate documentation of diagnoses as well
as laboratory results and medication orders; specifically,
when diagnoses are listed in progress notes, the EMR auto-
matically uses them to populate the problem list. Second, as
noted by Gill and Chen8 regarding MQIC in particular,
‘‘there may be differences between EHR users in general and
those who participate in MQIC…while MQIC includes a
large and diverse group of providers, participation is vol-
untary, so there may be some self-selection. For example, one
reason that practices join MQIC is to have access to quality
reporting. It may be that practices that are more interested in
measuring (and improving) quality of care are more likely to
join MQIC.’’ It is a reasonable inference that providers who
use the Centricity EMR and participate in MQIC document
diagnoses more completely and thoroughly than other pro-
viders. If this is the case, the key findings of the present
analysis – substantially higher proportions of visits for key
chronic conditions in Centricity compared to NAMCS -
represent not an overestimate but an accurate estimate of the
distribution of diagnoses in ambulatory visits in the United
States.
Limitations
The limitations of this study generally stem from the
methodological differences between the NAMCS and Cen-
tricity EMR data sets. Although NAMCS data collection is
based on probability sampling techniques that support esti-
mates for the United States as a whole, there is no such
methodology and capability in the Centricity database. Thus,
differences in results derived from the 2 data sets may reflect
a variety of factors including, among others, the age, sex, and
other demographic characteristics of the patients whose
visits were captured; the clinical characteristics of those
patients; and the characteristics of the physicians who use
the Centricity EMR, which may, in turn, be associated with
patients’ demographic and clinical characteristics.
As already described, several approaches were employed
to reduce the effects of such methodological artifacts. Speci-
fically, exclusion criteria were employed to reduce potential
overestimation of patients’ diagnoses in Centricity: (1) fil-
tering problem/complaint text extracted from records to
guarantee that patients merely evaluated for a condition
(without confirmation of diagnosis) were not counted as
‘‘positives’’ along with patients explicitly diagnosed with that
condition; and (2) excluding retrospective visit data that was
‘‘backfilled’’ when providers first adopted the Centricity
EMR. However, available data do not allow assessment of
the success of these strategies at eliminating all duplication
and overestimation.
More generally, analyses of EMR data are subject to the
same limitations posed by any use of paper or electronic
medical records; data will not be available in the medical
record if they were not available to the physician. Such gaps
result whenever patients receive care from other providers
but documentation is not provided to the original physician.
Moreover, gaps may result to the degree that paper-based
documentation is not transferred to the EMR and to the
degree that there are free-text data in the EMR that are not
available for analysis because of the complexities and costs of
such text mining.
Among the specific potential limitations of the Centricity
EMR database are that data on a single patient may be in-
cluded in the database with more than 1 patient identifier,
allowing for duplication and overestimation when aggregate
data are analyzed. Additionally, data reflect problems or
complaints, rather than ICD-9-CM diagnoses, as are used in
NAMCS; as a result, analyses must begin by searching the
entire patient record, including multiple codes and text
strings, to guarantee a comprehensive search for and valid
identification of diagnoses. A final limitation is the rate of
missing data on race/ethnicity in the Centricity data, which
was too high to allow comparisons with the NAMCS data.
On the other hand, among the strengths of the Centricity
EMR database are its incorporation of documentation of a
wide range of diagnostic and therapeutic services, specifi-
cally laboratory test results (with exact values and units of
measurement) and medications ordered, and, perhaps most
importantly, all of these types of data at multiple points in
time, allowing longitudinal analyses not possible with most
federal data sets, including NAMCS.
It is expected that use of ambulatory EMR systems like GE
Centricity will expand substantially during the next decade.
Many general trends and, specifically, increased federal in-
centives will combine to increase EMR utilization, increase the
number of patients whose records will be incorporated in
EMRs andEMR-based researchdatabases such asGECDSand
MQIC, and increase the number of years of continuous patient
data available for longitudinal research including outcomes
research, quality measurement, and research on quality.
A broad range of clinical research will be facilitated by in-
creasing EMR utilization and the increasing size, scope, and
span of EMR-based databases. One way of projecting the
potential for such studies is to examine the range of studies
conducted to date using GE Centricity data. A recent list of
such publications shows 12 articles published in peer-
reviewed journals from 2006-2008 and 31 presentations at
professional society meetings from 2004-2008. Among the
topics of the journal articles were quality of care for patients
with diabetes; oral antidiabetic medication use and outcomes
(2 articles); cardiometabolic risk factors; the effectiveness of
statins to lower low-density lipoprotein cholesterol (2 articles);
the effects of a randomized controlled trial on antihyperten-
sive prescribing; gastrointestinal complications of over-the-
counter NSAIDs; effects of second-generation antipsychotics
on weight gain; diagnosis, treatment, and/or outcomes for
COPD (2 articles); and antibiotic use for adult upper respira-
tory infections. Undoubtedly, the range of conditions and
outcomes studied will grow. In particular, studies of rare
conditions and outcomes will become more common, given
the huge numbers of cases available for longitudinal analyses
as well as the ever-widening time span.
Conclusions
This study has compared key demographic characteristics
(ie, age, sex) and clinical characteristics (ie, diagnoses) in the
GE Centricity EMR database and the federal NAMCS.
Compared to NAMCS patient visits, Centricity EMR patient
visits are somewhat more likely to involve younger patients
and considerably more likely to involve females. Centricity
visits include lower percentages of the more severe chronic
conditions of neoplasms and circulatory conditions and
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higher percentages of respiratory conditions, suggesting that
there is a higher proportion of visits for acute conditions in
the Centricity database and a higher proportion of visits for
chronic conditions in NAMCS. However, regarding the 13
chronic conditions highlighted by NAMCS, Centricity data
show a substantially higher proportion of visits for such
conditions in general, and for 12 of the 13 specific conditions.
While Centricity EMR data and results are not perfectly
comparable to NAMCS data and results, Centricity data may
actually be more sensitive in capturing diagnoses, especially
chronic condition diagnoses.More research is needed to assess
the validity and utility of Centricity and other EMR databases,
and, specifically, to assess the potential for evolving method-
ologies to maximize such validity and utility.
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